354 Results (Page 10 of 15)
Kenya Markets Research Reports
Kenya Transdermal Skin Patches Market Analysis
Kenya Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.
Kenya Transthyretin Amyloidosis (ATTR) Market Analysis
Kenya Transthyretin Amyloidosis (ATTR) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transthyretin Amyloidosis (ATTR) market is growing globally due to the increase in disease awareness, advancements in diagnostic techniques, development of disease-modifying therapies, growing investment in research and development, regulatory support and expedited approvals, collaboration and partnerships between pharmaceutical companies and academic institutions. Pfizer Inc, AstraZeneca, Prothena Corporation plc, Ionis Pharmaceuticals, BELLUS Health Inc , Alnylam Pharmaceuticals, Inc, Eidos Therapeutics, Inc, SOM BIOTECH, Abbvie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc. are the key global market players in transthyretin amyloidosis (ATTR) market.
Kenya Type 1 Diabetes Mellitus Drugs Market Analysis
Kenya Type 1 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 1 Diabetes Mellitus Drugs market is growing globally due to the rising prevalence of type 1 diabetes mellitus, advancements in insulin therapies, technological advancements in insulin delivery systems, increasing focus on personalized medicine, rising healthcare expenditure, favorable reimbursement policies, increasing patient awareness and education, research and development initiatives and collaborations between pharmaceutical companies and academic institutions. Novo Nordisk, Eli Lilly and Company, Sanofi, Medtronic, Abbott Laboratories, Dexcom, Zealand Pharma, Xeris Pharmaceuticals, Insulet Corporation, and Tandem Diabetes Care are the key global market players in type 1 diabetes mellitus drugs market.
Kenya Type 2 Diabetes Mellitus Drugs Market Analysis
Kenya Type 2 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 2 Diabetes Mellitus Drugs market is growing globally due to the increasing prevalence of Type 2 diabetes, growing awareness and diagnosis about the disease, advancements in drug therapies, rising geriatric population, government initiatives and healthcare policies, technological advancements in drug delivery, increasing research and development activities and rising healthcare infrastructure. Novo Nordisk, Sanofi, Eli Lilly and Company, Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Novartis International are the key global market players in type 2 Diabetes Mellitus Drugs Market.
Kenya Tyrosine Kinase Inhibitors Market Analysis
Kenya Tyrosine Kinase Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Tyrosine Kinase Inhibitors market is growing globally due to the Increasing prevalence of cancer, increasing use instead of conventional medicines due to their benefits, including the simplicity of oral administration, the capacity to target various cellular survival pathways, and the surge in demand for novel medications. The market is also influenced by an increase in pharmaceutical company investment and the utilization of cell processes to control different cell activities in cancer. Additionally, the market for tyrosine kinase inhibitors is positively impacted by increase in healthcare spending, awareness, population growth, increased healthcare infrastructure, and improvements in cancer treatments. F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Ascentage Pharma, AstraZeneca, Eisai Co., Ltd., Novartis AG, Sanofi, Bristol-Myers Squibb Company, Genentech, Inc., Pfizer Inc., Merck & Co., Inc., Suzhou Zelgen Biopharmaceuticals Co., Ltd., Celldex Therapeutics, Exelixis, Inc., Sino Biological Inc., AB Science, Bayer AG Deciphera Pharmaceuticals, Inc., and Johnson & Johnson Services, Inc are the key global market players in tyrosine kinase inhibitors market.
Kenya Ulcerative Colitis Market Analysis
Kenya Ulcerative Colitis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Ulcerative Colitis market is growing globally due to the increasing prevalence of ulcerative colitis, advancements in treatment options like introduction of biologic therapies, such as anti-TNF agents, anti-integrin agents and JAK inhibitors, rising awareness and diagnosis about disease, personalized medicine approaches, research and development initiatives, collaborations and partnerships between pharmaceutical companies and academic institutions. Johnson and Johnson, AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc., Novartis AG, Bausch Health Companies Inc. are the key global market players in ulcerative colitis market.
Kenya Unresectable Hepatocellular Carcinoma Market Analysis
Kenya Unresectable Hepatocellular Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Unresectable Hepatocellular Carcinoma market is growing globally due to the increasing incidence of unresectable hepatocellular carcinoma which is mainly due to rise in risk factors such as chronic hepatitis B and C infections, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and obesity. Advancements in diagnostic techniques like imaging techniques and biopsy, introduction of targeted therapies, immunotherapies, rising emphasis on combination therapies, clinical Trials and research initiatives. Bayer AG, Bristol Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Ipsen Pharma, Merck & Co., Inc., Novartis International AG, Roche Holding AG, Sanofi S.A., Takeda Pharmaceutical Company Limited are the key global market players in unresectable hepatocellular carcinoma market.
Kenya Urothelial Carcinoma Market Analysis
Kenya Urothelial Carcinoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Urothelial Carcinoma market is growing globally due to the increasing incidence and prevalence of urothelial carcinoma due to aging population, smoking, exposure to certain chemicals, and chronic bladder inflammation, advancements in diagnostic techniques like urinary biomarkers, cystoscopy, development of novel therapies like targeted therapies or immune checkpoint inhibitors and increased focus on personalized medicine. AstraZeneca PLC, Bristol Myers Squibb Company, Eli Lilly and Company, Genentech, Inc. (a member of the Roche Group), Merck & Co., Inc., Novartis AG, Pfizer Inc., Seattle Genetics, Inc., Sanofi S.A., Johnson & Johnson are the key global market players in urothelial carcinoma market.
Kenya Varicella Vaccine Market Analysis
Kenya Varicella Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Varicella Vaccine market is growing globally due to the increasing vaccination coverage, growing public awareness about varicella vaccination, well established safety and efficacy profile of varicella vaccine, launch of varicella control programs by various governments. Merck & Co., Inc., GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Changchun BCHT Biotechnology Co., Ltd., Sinovac Biotech Ltd., Kaketsuken (Japan Blood Products Organization) and Shanghai Institute of Biological Products are the key global market players.
Kenya Viscosupplementation Market Analysis
Kenya Viscosupplementation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Viscosupplementation market is growing globally due to the increasing prevalence of osteoarthritis, growing aging population, and rising awareness about minimally invasive treatment options, increasing awareness and acceptance, technological advancements in viscosupplementation treatments, rise in the healthcare sector spending and infrastructure. Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V, sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW are the key global market players of viscosupplementation market.
Kenya Vision Care Market Analysis
Kenya Vision Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Vision Care market is growing globally due to the increasing prevalence of eye disorders such as myopia, hyperopia, astigmatism, and age-related macular degeneration (AMD), surging volume of patients suffering from chronic diseases which will led to the occurrences of vision ailments, improper intake of nutrition and unhealthy food eating habits, technological advancements in vision care industry like innovations in lens materials, frame designs, and contact lens technologies, increasing awareness about the importance of regular eye exams and eye health initiatives by governments, healthcare organizations and growth of the e-commerce sector. EssilorLuxottica, Johnson & Johnson, Novartis AG (Alcon), CooperVision, Bausch Health Companies (Bausch + Lomb), Zeiss, Hoya Corporation, Safilo Group and Carl Zeiss Meditec are the key global market players.
Kenya Wearable Injectors Market Analysis
Kenya Wearable Injectors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Wearable Injectors market is growing globally due to the strong healthcare infrastructure, rise in the incidence of lifestyle disorders, an ageing population that is more susceptible to diseases, increase in the desire for minimally invasive (MI) treatment alternatives, rise in chronic diseases like diabetes, autoimmune diseases, patient preference for self-administration medications in the comfort of their homes which enhances patient convenience, improves medication adherence, technological advancements in wearable injector technology which have improved device usability, functionality, patient experience. Continuous drug delivery provided by wearable injectors like more stable drug levels, reduced fluctuations, focus on patient centric care and cost-effective solutions provided by wearable injectors. Medtronic plc, Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections, SteadyMed Therapeutics, Inc., Sensile Medical AG, CeQur SA, Ypsomed AG, Becton, Dickinson and Company and Tandem Diabetes Care, Inc. are the key global market players in wearable injectors market.
Kenya Anemia Therapeutics Market Analysis
The Kenya Anemia Therapeutics Market is anticipated to experience growth from $10 Mn in 2022 to $23 Mn by 2030, with a CAGR of 10.2% during the forecast period of 2022-2030. The growth of the Kenya anemia therapeutics market is primarily propelled by the high burden of anemia, particularly among pregnant women and young children, along with government initiatives, awareness programs, and increased accessibility to diagnostic testing and affordable treatment options. The Kenya Anemia Therapeutics Market encompasses various players across different segments, including Pfizer, Novartis, Sanofi, GlaxoSmithKline (GSK), AstraZeneca, Bayer, Amgen, Cipla, Pharmchem, Alphapharm, Medisys Laboratories etc, among various others.
Kenya Dermatological Therapeutics Market Analysis
Kenya Dermatological Therapeutics Market is at around $0.03 Bn in 2023 and is projected to reach $0.06 Bn in 2030, exhibiting a CAGR of 9.7% during the forecast period. The expansion of the market is driven by factors such as government initiatives, healthcare infrastructure development, changing lifestyles, and environmental factors. The market is dominated by key players like Glenmark Pharmaceuticals, Universal Pharmaceuticals Limited, Cosmos Limited, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.
Kenya Alopecia (Hair Loss) Therapeutics Market Analysis
The Kenya Alopecia (Hair Loss) Therapeutics Market was valued at US $6 Mn in 2022, and is predicted to grow at (CAGR) of 8.6% from 2023 to 2030, to US $11 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), the evolving treatment landscape, and others. The industry is primarily dominated by players such as Roche, Johnson & Johnson, Bayer, Sanofi, Lexington, and Merck, among others.
Kenya Digital Therapeutics Market Analysis
Kenya Digital Therapeutics Market is at around $4 Mn in 2023 and is projected to reach $22.89 Mn in 2030, exhibiting a CAGR of 28.3 % during the forecast period. Government support, partnerships and collaborations, and the expansion of telemedicine are the factors propelling the market's growth. The market is dominated by key players like Afya Pap, Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.
Kenya Allergy Therapeutics Market Analysis
Kenya Allergy Therapeutics Market was valued at $16 Mn in 2022 and is estimated to reach $29 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The growing numbers of allergic disorders and associated health problems is driving up the need for allergy treatment drugs. GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Bayer, Pfizer, Abbott, Pharmanet Kenya Ltd., Mepharm Kenya Ltd. and Mediheal Kenya Ltd. are top leading pharmaceutical companies that are currently operating in the market.
Kenya Alcohol Addiction Therapeutics Market Analysis
The Kenya Alcohol Addiction Therapeutics Market is valued at around $5 Mn in 2022 and is projected to reach $8 Mn by 2030, exhibiting a CAGR of 7.5% during the forecast period. The increasing prevalence of alcohol use, increased awareness and destigmatization efforts along with the development of healthcare infrastructure, as well as the government initiatives to integrate and improve AUD treatment within primary healthcare services are all factors driving the Kenya Alcohol Addiction Therapeutic Market. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Kenya are Alkermes, Teva Pharmaceuticals, BioCorRx, Adial Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), Merck & Co., Kinnov Therapeutics, Omeros Corporation etc among others.
Kenya Cardiovascular Drugs Market Analysis
Kenya Cardiovascular Drug Market is at around $0.1 Bn in 2022 and is projected to reach $1.4 Bn in 2030, exhibiting a CAGR of 4.9% during the forecast period. Increased burden of cardiovascular diseases, government support & policies, and increased public awareness are driving the growth of the market. The market is dominated by key players like Regal Pharmaceuticals (KEN), Transwide Pharmaceuticals (KEN), Bristol-Myers Squibb Co., F. Hoffman-La Roche, Pfizer Inc., Astra Zeneca, Merck & Co., Sanofi, Novartis, and GSK.
Kenya Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Kenya Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $2 Mn in 2022, and is predicted to grow at (CAGR) of 8.9% from 2023 to 2030, to US $5 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, high unmet needs, increased government initiatives, and other factors. The industry is primarily dominated by players such as Universal Corporation, Bio-Ken, Toxin, Avenue Healthcare, and Novartis among other players
Kenya Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Kenya Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $0.8 Mn in 2022, and is predicted to grow at (CAGR) of 6.9% from 2023 to 2030, to US $1.4 Mn by 2030. The key drivers of this industry include the several government initiatives and policies to support rare diseases and increased awareness among the population regarding the condition. The industry is primarily dominated by players such as Otsuka Pharmaceutical, AceLink Therapeutics, Palladio Biosciences, Reata Pharmaceutica, Xortx, Regulus Therapeutics, Galapagos NV among others
Kenya Age-Related Macular Degeneration Therapeutics Market Analysis
The Kenya Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $8 Mn in 2022, and is predicted to grow at (CAGR) of 10% from 2023 to 2030, to US $16 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, evolving healthcare infrastructure, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others
Kenya Addiction Therapeutics Market Analysis
Kenya addiction therapeutics market was valued at $7 Mn in 2022 and is estimated to reach $13 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The anti-drug campaigns and supportive government initiatives have increased public awareness, which has led to a notable expansion of the addiction therapeutic industry. AbbVie, Indivior, Reckitt Benckiser Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Alkermes, Lupin Pharmaceuticals, and Cipla are some of the leading companies operating in the market
Kenya Adult Malignant Glioma Therapeutics Market Analysis
The Kenya Adult Glioma Therapeutics Market is valued at around $2 Mn in 2022 and is projected to reach $3 Mn by 2030, exhibiting a CAGR of 10% during the forecast period. Growth in the Kenya Adult Malignant Glioma Market is driven by a dynamic combination of factors, including growing awareness of early detection, government funding, increased research for inexpensive medicines, and the impending burden of Glioma. Key players in the Kenya Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, M Pharm, Brainlab, Siemens, etc. among others.
Kenya ePharmacy Market Analysis
This report presents a strategic analysis of the Kenya ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Kenya ePharmacy Market, offering unmatched value, accuracy, and expert insights.